<DOC>
	<DOC>NCT00407004</DOC>
	<brief_summary>This trial compares the efficacy of two artificial liver support systems, MARS (Molecular Adsorbents Recirculating System) and Prometheus (FPSA, Fractionated Plasma Separation and Adsorption), in removing albumin-bound substances such as bilirubin, bile acids, and cytokines.</brief_summary>
	<brief_title>Elimination of Albumin-Bound Substances by MARS and Prometheus</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>consecutive patients with acuteonchronic liver failure (severe deterioration of chronic liver disease) unresponsive to standard medical treatment for &gt;=48 hours arterial hypotension extrahepatic malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines</keyword>
</DOC>